Drugs / BI 730460
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03483077 | Oct 2018 → Mar 2019 | — | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 730460 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03483077 ↗ |
| Route | Oral | “following oral administration” NCT03483077 ↗ |